{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-093291","form_type":"8-K","ticker":"SYBX","cik":"0001527599","company_name":"SYNLOGIC, INC.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.384243+00:00","generated_at":"2026-05-31T10:52:51.950044+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Synlogic reports Q2 net income $2M on restructuring gain; exploring strategic options","bullets":["Cash and equivalents $20.0M as of June 30, 2024.","Net income $2.0M ($0.16/share) vs net loss $15.0M ($3.21/share) in Q2 2023; revenue zero.","R&D expenses fell to $2.2M from $11.8M YoY; restructuring gain of $3.8M from lease termination.","Retained Lucid Capital Markets to evaluate strategic alternatives including acquisition or merger.","In Feb 2024, discontinued pivotal PKU study (Synpheny-3) and reduced workforce."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-093291","json":"https://secwatch.observer/filing/0000950170-24-093291.json","markdown":"https://secwatch.observer/filing/0000950170-24-093291.md","text":"https://secwatch.observer/filing/0000950170-24-093291.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527599/000095017024093291/0000950170-24-093291-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527599/000095017024093291/sybx-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:52:51.950044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}